Australian experts continually grapple with geographic distance from (mostly) northern hemisphere peers. To overcome this, Melbourne Genomics focused particular effort on international and national engagement during the 2016 to 2019 program.

A strategy was developed to:

  • Give profile to the unique strengths of Melbourne Genomics’ members and the outcomes of their collaboration

  • Ensure Victoria benefits from the best of global knowledge

  • Assert and enhance Victoria’s profile as a leader in bringing genomics into healthcare

  • Establish a strong foundation for future opportunities in genomics

A key element of this strategy was a program to attract international expert visitors to spend time in Melbourne, and to send Melbourne Genomics experts to spend time with peers outside Australia.

Project description

The objective: to share knowledge and experience and bring the best of the world’s expertise to benefit Victoria, by facilitating face-to-face, person-to-person immersive contact between international peers.

The visits and visitors program had three distinct categories:

  • Experts-in-Residence: Clinical Flagships and Advisory Groups nominated an expert of their choice to host in Melbourne for one to two weeks. Experts were embedded within the Flagship or Group to facilitate mutual sharing of knowledge, skills and experience.

  • Immersion Visits: Melbourne Genomics leaders invited highly-placed opinion leaders in genomics for a one-week visit to directly experience the Alliance and its work.

  • Alliance Ambassadors: early-to-mid career professionals from the Melbourne Genomics member organisations selected to travel nationally or internationally to achieve a specific linking or learning goal, with new knowledge and experience to be shared on their return.


Between January 2017 and December 2019, Melbourne Genomics hosted 12 Experts-in-Residence and three Immersion Visitors, and supported five Alliance Ambassadors.

Notable visitors included:

  • Professor Yehuda Carmeli, Founder and Head of the Division of Epidemiology at Tel Aviv Medical Center and of the National Institute for Infection Control and Antibiotic Resistance (2018).

  • Danielle Ciofani, Director of Data Strategy and Alliances at the Broad Institute of Harvard University and MIT (2018)

  • Professor Anthony Brookes, Professor of Genetics at the University of Leicester, who led the Global Alliance for Genomics and Health’s standard ‘ADA-M’ – a computer-readable model for consent and data use conditions (2019)

  • Professor Dame Sue Hill DBE, Chief Scientific Officer and Senior Officer Responsible for Genomics at NHS England, a globally recognised leader in genomics (2019)

  • Jillian Hastings Ward, Chair of the Participant Panel for the 100,000 Genomes Project (2019)


Professor Carmeli’s visit resulted in his team establishing links with Victorian genomics experts. This has subsequently led to Israeli superbug isolates being sent to Melbourne for whole genome sequencing as part of an outbreak investigation.

Professor Hill and Jillian Hastings Ward’s visit resulted in significant media exposure and raised interest from local and global experts in Melbourne Genomics’ program of work.

Strong links were built with individual experts, their organisations and their networks.

Victoria has benefited from global knowledge, and there has been national and international recognition for the Melbourne Genomics program and lessons learned as a result of these visits.

Melbourne Genomics’ collaborative model has become recognised as the international gold standard for bringing genomics into healthcare. This has resulted in international recognition for Victoria, as well as worldwide profile and linkages for Victoria’s experts.

Lessons learnt

  • There was significant value for the Clinical Flagships, Advisory Groups and Melbourne Genomics program team in the opportunity to discuss issues/challenges with experts face-to-face – often resulting in validation that the problems encountered were shared (despite differences of geography, systems, etc).

  • The visits and visitors program made enduring connections with experts in similar fields. There was significant value in being able to collaborate with experts in niche fields.

Full list of visits and visitors


Visitor type



Host group

Immersion visitor

Prof Anthony Brookes

Professor of Genetics, University of Leicester, United Kingdom

Alliance management

Immersion visitor

Prof Dame Sue Hill

Chief Scientific Officer and Senior Officer Responsible Officer for Genomics, NHS England, United Kingdom

Alliance management

Immersion visitor

Prof Yehuda Carmeli

Founder and Head of Division of Epidemiology at Tel Aviv Medical Center and the National Institute for Infection Control and Antibiotic Resistance, Israel

Controlling Superbugs Clinical Flagship


Dr Austin Kulasekararaj

Consultant Haematologist, King’s College Hospital, United Kingdom

Bone Marrow Failure Clinical Flagship


Broad Institute visitors:
Danielle Ciofani*
Alex Baumann**

*Director of Data Strategy and Alliances

**Senior Software Developer

Broad Institute, USA

GenoVic Project Control Group


Dr Cynthia Powell

Professor of Paediatrics and Genetics, University of North Carolina, USA

Congenital Deafness Clinical Flagship


Dr Daniel Gale

St Peter’s Associate Professor of Nephrology, University College London, United Kingdom

Kidney Genetics Clinical Flagship


Ellen Graham

Deputy Director, Genomics Unit, NHS England, United Kingdom

Alliance management


Prof Glenda Halliday

NHMRC Senior Principal Research Fellow Central Clinical School, University of Sydney

Complex Neurological and Neurodegenerative Diseases Clinical Flagship


Dr James Holman

Research Environment Programme Lead at Genomics England, United Kingdom

GenoVic Project Control Group


Dr Jennelle Hodge

Associate Professor of Clinical Medical & Molecular Genetics, Indiana University

Lymphoma Clinical Flagship


Ivo Fokkema

Leiden Open Variation Database developer, Leiden University Medical Center, Netherlands

Diagnostic Advisory Group


Jillian Hastings Ward

Chair of the Participant Panel, 100,000 Genomes Project, United Kingdom

Community Advisory Group


Dr Kilannin Krysiak

Clinical Fellow, Department of Pathology and Immunology, Washington University School of Medicine, USA

Diagnostic Advisory Group

Alliance Ambassador

Dr Anna Tanska

Laboratory Scientist/Manager Molecular Pathology, Peter MacCallum Cancer Centre

American Society of Human Genetics Annual Meeting

Alliance Ambassador

Dr Claire Gorrie

Lead Bioinformatician, Controlling Superbugs Clinical Flagship

Dr Estee Torok (jointly appointed across the University of Cambridge, Addenbrookes Hospital, and the Sanger Institute at the Wellcome Trust Genome Campus)

Alliance Ambassador

Dr Dhamidhu Eratne

Key Clinician, Complex Neurological and Neurodegenerative Diseases Clinical Flagship

American Society of Human Genetics Annual Meeting

Alliance Ambassador

Dr Lilian Downie

Key Clinician, Congenital Deafness Clinical Flagship

Broad Institute, Partners Healthcare Laboratory Molecular Medicine, Seqaboo team at Harvard Medical School

Alliance Ambassador

Lyndon Gallacher

Genetic Counsellor, Victorian Clinical Genetics Services/Murdoch Children’s Research Institute

Daniel MacArthur Laboratory, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA






We could talk genomics all day, but we’ll send you only what’s useful and interesting.

Melbourne Genomics acknowledges the Wurundjeri people of the Kulin Nation, on whose lands we work, and all First Nations peoples across Victoria. We pay respect to Elders past and present. We also acknowledge the First Nations health professionals, researchers and leaders who are shaping the future of genomic medicine.

© 2014–2024 Melbourne Genomics Health Alliance